Editorial companion

What stands out

The host flags a split earnings day where Fortinet and Caterpillar surprised traders with slowing product and end-market revenue growth while Eli Lilly posted another growth beat driven by Mounjaro and Zepbound. The striking part is momentum: Fortinet and Caterpillar fell hard despite mixed earnings results, while Lilly’s drug momentum sent the stock higher, showing how headline drug growth can override broader macro jitters in a single session. The segment captures a market sorting between defensive tech and biotech winners during earnings flow.